Aethlon Medical (AEMD) Earning Somewhat Favorable Press Coverage, Report Finds

Media stories about Aethlon Medical (NASDAQ:AEMD) have trended somewhat positive on Sunday, Accern Sentiment reports. The research group scores the sentiment of press coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Aethlon Medical earned a coverage optimism score of 0.21 on Accern’s scale. Accern also assigned news headlines about the medical equipment provider an impact score of 46.6662822687706 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

Separately, HC Wainwright initiated coverage on Aethlon Medical in a research note on Monday, November 20th. They set a “buy” rating and a $3.00 price target for the company.

Aethlon Medical (AEMD) traded up $0.01 on Friday, hitting $1.53. The stock had a trading volume of 149,030 shares, compared to its average volume of 434,716. Aethlon Medical has a 52 week low of $0.79 and a 52 week high of $5.17. The company has a debt-to-equity ratio of 0.18, a current ratio of 17.03 and a quick ratio of 17.03. The stock has a market cap of $25.37, a P/E ratio of -2.35 and a beta of 2.27.

Aethlon Medical (NASDAQ:AEMD) last posted its quarterly earnings results on Friday, February 9th. The medical equipment provider reported ($0.08) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.11) by $0.03. The firm had revenue of $0.08 million for the quarter, compared to analysts’ expectations of $0.08 million. equities analysts forecast that Aethlon Medical will post -0.48 earnings per share for the current year.

WARNING: “Aethlon Medical (AEMD) Earning Somewhat Favorable Press Coverage, Report Finds” was originally posted by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are viewing this news story on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The original version of this news story can be accessed at

About Aethlon Medical

Aethlon Medical, Inc is a medical device company focused on creating devices for cancer, infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities.

Insider Buying and Selling by Quarter for Aethlon Medical (NASDAQ:AEMD)

Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with's FREE daily email newsletter.

Leave a Reply